Posterolateral lumbar spine fusion with INFUSE bone graft

Spine Journal

Volumn 7, Issue 1, 2007, Pages 44-49

  Glassman, Steven D ^a,b   Carreon, Leah ^b   Djurasovic, Mladen ^a,b   Campbell, Mitchell J ^a,b   Puno, Rolando M ^a,b   Johnson, John R ^a,b   Dimar, John R ^a,b  

^a University of Louisville School of Medicine   (United States)

^b NORTON LEATHERMAN SPINE CENTER   (United States)

Author keywords

Bone graft; INFUSE; Lumbar spine fusion; Nonunion rate

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; AGED; ARTICLE; BONE TRANSPLANTATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; ILIAC CREST; IMAGE RECONSTRUCTION; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK DISEASE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDARTHROSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCOLIOSIS; SEX DIFFERENCE; SMOKING; SPINE FUSION; SPONDYLOLISTHESIS; STATISTICAL SIGNIFICANCE; SURGEON; SURGICAL RISK; SURGICAL SPONGE; SURGICAL TECHNIQUE; VERTEBRAL CANAL STENOSIS; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEINS; BONE SUBSTITUTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMPLANTS, EXPERIMENTAL; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSSEOINTEGRATION; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPINAL FUSION; TREATMENT OUTCOME;

EID: 33845778114     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2006.06.381     Document Type: Article

References (24)

1. Luhmann S.J., Bridwell K.H., Cheng I., et al. Use of bone morphogenetic protein-2 for adult spinal deformity. Spine 30 17S (2005) S110-S117
2. Dimar JR, Glassman SD, Burkus K, et al., Clinical outcomes and fusion success at two years of single level instrumented posterolateral fusions with rhBMP-2 CRM vs. iliac crest bone graft. Paper presented at: 20th Annual Meeting of the North American Spine Society; September 28, 2005; Philadelphia, PA.
3. Schwender J.D., Holly L.T., Rouben D.P., et al. Minimally invasive transforaminal lumbar interbody fusion (TLIF): technical feasibility and initial results. J Spinal Disord Tech 18 (2005) S1-S6
4. Mummaneni P.V., Pan J., Haid R.W., et al. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. J Neurosurg (Spine 1) 1 (2004) 19-23
5. Haid R.W., Branch C.L., Alexander J.T., et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 4 (2004) 527-539
6. Baskin D.S., Ryan P., Sonntag V., et al. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the Cornerstone-SR allograph ring and the Atlantis anterior cervical plate. Spine 28 (2003) 1219-1225
7. Boakye M., Mummaneni P.V., Garrett M., et al. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg (Spine 2) 2 (2005) 521-525
8. Lanman T.H., and Hopkins T.J. Early findings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein-2 was used with poly(Lactide-co-D, L-lactide) bioabsorbable implants. Neurosurg Focus 16 (2004) article 6
9. Burkus J.K., Gornet M.F., Dickman C.A., et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cases. J Spinal Disord Techniques 15 (2002) 337-349
10. Burkus J.K., Sandhu H.S., Gornet M.F., et al. Use of rhBMP-2 in combination with structural cortical allographs: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg 87-A (2005) 1205-1212
11. Boden S.D., Kang J., Sandhu H., et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trail: 2002 Volvo award in clinical studies. Spine 27 230 (2002) 2662-2673
12. Biyani A, Rodway I, Assenmacher C, et al., Use of recombinant human bone morphogenic protein (rhBMP-2) without iliac crest bone graft in multilevel posterolateral spinal fusion in the elderly. Paper presented at International Society for the Study of the Lumbar Spine, New York, NY, May 10-15, 2005.
13. Abraham E.P., Alexander D.I., Bailey S.I., et al. Evaluation of a new rhBMP-2 formulation in two-level posterolateral lumbar spine fusion. Abstract presented to American Academy of Orthopaedic Surgeons (2005) No. 002
14. Alexander D.I., Abraham E.P., Bailey S.I., et al. A new rhBMP-2 formulation in posterolateral lumbar spine fusion; a prospective, randomized study. Abstract presented to the American Academy of Orthopaedic Surgeons (2005) No. 003
15. Singh K, Smucker J, Rhee J, Boden S. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion CT-scan analysis at one and two years. Spine J 2005;5:S31.
16. Glassman S., Dimar J., Carreon L., et al. Initial fusion rates with rh-BMP-2 and an HA-TCP/collagen carrier in posterolateral fusion. Spine 15 (2005) 1694-1698
17. Glassman S.D., Anagnost S.C., Parker A., et al. The effect of cigarette smoking and smoking cessation on spinal fusion. Spine 25 (2000) 2608-2615
18. Glassman S.D., Rose M., Dimar J.R., et al. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 23 (1998) 834-838
19. Carreon L.Y., Glassman S.D., Anekstein Y., et al. Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine 30 (2005) E243-E246
20. Suh D.Y., Boden S.D., Louis-Ugbo J., et al. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant Matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine 27 (2002) 353-360
21. Akamaru T., Suh D., Boden S.D., et al. Simple carrier Matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spinal fusion. Spine 28 (2003) 429-434
22. Barnes B., Boden S.D., Louis-Ugbo J., et al. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Spine 30 (2005) 1127-1133
23. Martin G.J., Boden S.D., Morone M.A., et al. Posterolateral intertransverse process spinal fusion arthrodesis with rhBMP-2 in a non-human primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12 (1999) 179-186
24. Glassman S.D., Alegre G., Carreon L., et al. Perioperative complications in patients with diabetes mellitus treated by lumbar instrumentation and fusion. Spine J 3 (2003) 496-501